Sidpra, Jai https://orcid.org/0000-0003-1985-5503
Lind, Valentina https://orcid.org/0009-0002-4842-6038
Cohen, Alexander L. https://orcid.org/0000-0001-6557-5866
Schaper, Frederic L. W. V. J. https://orcid.org/0000-0001-5487-0923
Stone, Thomas J.
Grabovska, Yura https://orcid.org/0000-0003-3419-2234
Biswas, Asthik
Sudhakar, Sniya
Sepulveda, Francisco https://orcid.org/0000-0003-1898-2869
Peres, Bruno S.
Veronese, Greta https://orcid.org/0009-0008-4955-1651
Alemán-Charlet, Cristina
Ogunbiyi, Olumide
Shamardani, Kiarash
Zhao, Jiaqi
Palacin, Alberto Castro
Miller, Gillian https://orcid.org/0009-0001-6306-8163
Opipari, Raffaella S. https://orcid.org/0000-0003-4156-9001
De Vita, Enrico https://orcid.org/0000-0001-8068-1288
Ridout, Deborah
Ferraciolli, Suely F.
Lucato, Leandro T.
Avsenik, Jernej https://orcid.org/0000-0003-4081-4140
Piccirilli, Eleonora https://orcid.org/0000-0003-3105-1292
Morales-La Madrid, Andrés
Muchart, Jordi https://orcid.org/0000-0003-4702-5072
Ryan, Maura E.
Patel, Rajan
Haldipur, Parthiv
Hill, Ciaran S. https://orcid.org/0000-0002-4488-4034
Krüger, Marie T.
Zrinzo, Ludvic
Jeelani, Noor ul Owase
Martinez-Barbera, Juan Pedro https://orcid.org/0000-0002-5292-7276
Donson, Andrew M.
Dorris, Kathleen
Morgan, Paul S. https://orcid.org/0000-0002-5870-1446
Mackay, Alan
Venkatesh, Humsa S. https://orcid.org/0000-0003-1194-3015
Horn, Andreas https://orcid.org/0000-0002-0695-6025
Mueller, Sabine https://orcid.org/0000-0002-8216-9357
Green, Adam L.
Mirsky, David M.
Akram, Harith
Jones, Chris
Aquilina, Kristian https://orcid.org/0000-0001-7015-5196
Mankad, Kshitij
Monje, Michelle https://orcid.org/0000-0002-3547-237X
Jacques, Thomas S. https://orcid.org/0000-0002-7833-2158
Fox, Michael D.
Hargrave, Darren R. https://orcid.org/0000-0001-8219-9807
Article History
Received: 26 February 2025
Accepted: 6 May 2026
First Online: 10 June 2026
Competing interests
: A.M.-L.M. is chief medical officer of Gate2Brain. A.H. reports lecture fees for Boston Scientific, is a consultant for and holds stock options of Modulight.bio, was a consultant for FxNeuromodulation in recent years and serves as a co-inventor on a patent granted to Charité University Medicine Berlin that covers multisymptom DBS fiberfiltering and an automated DBS parameter suggestion algorithm unrelated to this work (patent LU103178). M.M. holds equity in MapLight Therapeutics and Stellaromics, and is on the scientific advisory board of S1 Oncology. The other authors declare no competing interests.